Tag: Food and Drug Administration (FDA)
Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and...
Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older
Food Product Recalls Explained
Why are food products so often recalled and are they really that dangerous?
FDA Warns About Serious Health Problems with High Doses of Benadryl
Teen misuse sparked by dangerous “Benadryl Challenge” promoted on social media.
Four Changes the FDA Must Adopt to Make Ingredient Labeling Safer...
Suggestions that would make shopping easier, safer, and far less confusing for the allergic community.
The FASTER Act: What It Does and Why YOU Need to...
FARE can't do it alone: Do your part to help pass the FASTER Act.
FDA Denies Approval of Viaskin Peanut “Patch” Therapy
The FDA raised concerns that adhesion of the patch would affect the efficacy of the therapy.
Think You’ve Developed a Meat Allergy from a Tick Bite? There’s...
FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat.
Graphic Explains the Shortcomings in US Allergen Labeling Regulations Everyone Coping...
Download your copy to print at home and keep handy or share with family, friends, and your child's teacher.
Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...
Company is restructuring in anticipation of delays.
Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine
Epinephrine you slip under your tongue takes another step forward as the company submits their IND application.
